Company Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 03:51:21 2025-07-09 pm EDT			5-day change	1st Jan Change
786.13 ^USD	+1.09%		+0.99%	+1.94%

03:38pm	Sector Update: Health Care	MT
11:04am	Öhman Health and New Technology Fund Rises 3.9% in June - Camurus Surges After Eli Lilly Partnership	FW

Business description: Eli Lilly and Company

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (19.4%);

- immunology diseases (9.8%);

- neurology (3.3%): primarily drugs used in treating depression and schizophrenia;

- other (2%).

Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Number of employees: 47,000

Sales by Activity: Eli Lilly and Company

Fiscal Period: December	2020	2021	2022	2023	2024
Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products	24.54B	28.32B	28.54B	34.12B	45.04B

See all business segments

Geographical breakdown of sales: Eli Lilly and Company

Fiscal Period: December	2020	2021	2022	2023	2024
United States (U.S.)	14.23B	16.81B	18.19B	21.79B	30.38B
Europe	4.19B	4.78B	4.3B	6.17B	6.92B
Rest of world	2.42B	2.7B	2.85B	2.95B	4.27B
Japan	2.58B	2.37B	1.75B	1.67B	1.81B
China	1.12B	1.66B	1.45B	1.54B	1.66B

See all geographic segments

Executive Committee: Eli Lilly and Company

Manager	Title	Age	Since
David Ricks CEO	Chief Executive Officer	57	2016-12-31
Ruth Gimeno PSD	President	-	-
Lucas Montarce DFI	Director of Finance/CFO	48	2024-09-08
Diogo Rau CTO	Chief Tech/Sci/R&D Officer	50	2021-05-16
David Hyman CTO	Chief Tech/Sci/R&D Officer	-	2023-10-15

See ELI LILLY AND COMPANY governance

Composition of the Board of Directors: Eli Lilly and Company

Director	Title	Age	Since
Jon Fyrwald BRD	Director/Board Member	65	2004-12-31
Ralph Alvarez BRD	Director/Board Member	69	2009-03-31
Katherine Baicker BRD	Director/Board Member	53	2011-12-11
David Ricks CHM	Chairman	57	2017-05-31
William Kaelin BRD	Director/Board Member	67	2012-06-03
Juan Luciano BRD	Director/Board Member	63	2016-01-31
Jamere Jackson BRD	Director/Board Member	55	2016-09-30
Gabrielle Greene-Sulzberger BRD	Director/Board Member	64	2021-01-24
Kimberly Johnson BRD	Director/Board Member	52	2021-02-15
Mary Lynne Hedley BRD	Director/Board Member	62	2022-05-14

Composition of the Board of Directors

Shareholders: Eli Lilly and Company

Name	Equities	%	Valuation
Lilly Endowment, Inc. 10.13 %	96,016,978	10.13 %	74 848 M $
Lilly Endowment, Inc. 10.13 %	96,016,978	10.13 %	74 848 M $
Vanguard Fiduciary Trust Co. 8.359 %	79,224,392	8.359 %	61 758 M $
PNC Investments LLC 5.39 %	51,086,636	5.39 %	39 824 M $
BlackRock Advisors LLC 5.251 %	49,767,892	5.251 %	38 796 M $

Name	Equities	%	Valuation
Caixa DTVM SA 0.001404 %	399,230	0.001404 %	10 M $
Western Asset Management Company DTVM Ltda. 0.000551 %	156,709	0.000551 %	4 M $
BRAM - Bradesco Asset Management SA DTVM 0.000164 %	46,605	0.000164 %	1 M $
Safra Asset Management Ltda. 0.000154 %	43,800	0.000154 %	1 M $
XP Allocation Asset Management Ltda. 0.000026 %	7,367	0.000026 %	190 727 $

List of ELI LILLY AND COMPANY shareholders

Holdings: Eli Lilly and Company

Name	Equities	%	Valuation
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. 1.49%	6,097,792	1.49%	50,889,367 $
PROQR THERAPEUTICS N.V. 16.37%	16,895,100	16.37%	34,466,004 $
FOGHORN THERAPEUTICS INC. 7.19%	4,000,000	7.19%	18,800,000 $
PEIJIA MEDICAL LIMITED 2.98%	19,952,740	2.98%	16,445,048 $

Company details: Eli Lilly and Company

Eli Lilly & Co.

Lilly Corporate Center

46285, Indianapolis

+317 276 2000

http://www.lilly.com

Group companies: Eli Lilly and Company

Name	Category and Sector
Lilly Asia Ventures Fund II LP Lilly Asia Ventures Fund II LP Investment ManagersFinance Lilly Asia Ventures Fund II LP invests in companies located in China and the United States. The fund targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices, and diagnostics. It provides financing in the form of equity for seed, early and growth stage capital requirements.	Investment Managers
Eli Lilly (Suisse) SA	Miscellaneous Commercial Services
Eli Lilly Kinsale Ltd. Eli Lilly Kinsale Ltd. Pharmaceuticals: OtherHealth Technology Eli Lilly Kinsale Ltd., part of Eli Lilly & Co., is a company headquartered in Kinsale, Ireland, that manufactures medicines.	Pharmaceuticals: Other
Lilly Ventures Fund I LLC Lilly Ventures Fund I LLC Investment ManagersFinance Lilly Ventures Fund I LLC seeks investment opportunities located in the North American and European regions. The fund targets companies operating in the fields of biotechnology, medical technology and healthcare IT. It provides financing for early stage capital requirements.	Investment Managers
Eli Lilly Vostok SA

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ELI LILLY AND COMPANY	+1.09%	+0.99%	-15.60%	+137.71%	698B
JOHNSON & JOHNSON	+0.02%	+0.11%	+5.90%	-12.68%	375B
ABBVIE INC.	+0.41%	-0.10%	+13.39%	+24.36%	335B
NOVO NORDISK A/S	-1.53%	+0.35%	-54.14%	+9.26%	313B
ROCHE HOLDING AG	+0.89%	-0.04%	+6.30%	-20.36%	259B
NOVARTIS AG	-0.16%	-0.89%	+0.47%	+17.53%	240B
ASTRAZENECA PLC	+0.21%	-0.27%	-13.25%	-7.10%	217B
MERCK & CO., INC.	+2.88%	+1.86%	-33.42%	-11.01%	204B
AMGEN INC.	-0.21%	+0.01%	-6.03%	+19.81%	160B
PFIZER, INC.	-0.41%	+0.67%	-8.04%	-51.81%	146B
Average	+0.30%	+0.74%	-10.44%	+10.57%	294.8B
Weighted average by Cap.	+0.39%	+0.50%	-10.60%	+31.62%